Celecoxib and rofecoxib
- 1 April 2001
- journal article
- research article
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 132 (4) , 451-456
- https://doi.org/10.14219/jada.archive.2001.0207
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Over-the-counter analgesics and antipyretics: A critical assessmentPublished by Elsevier ,2000
- Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled TrialThe Journal of Clinical Pharmacology, 2000
- Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trialClinical Therapeutics, 1999
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998
- Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionThe Journal of Clinical Pharmacology, 1991
- New Aspects of the Mode of Action of Nonsteroid Anti-Inflammatory DrugsAnnual Review of Pharmacology, 1974
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- Aspirin and UlcerBMJ, 1955